Company Profile - JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED สำนักงานคณะกรรมการกำกับหลักทรัพย์และตลาดหลักทรัพย์ Printed on 09 August 2024 20:12 Company Profile JSP
1 No. ECF2 029/2561 28 June 2018 Subject The Entering into an Investment of the construction of the Manufacturing Plant and Distributing of the Medium Density Fiber Board or MDF Board in Narathiwat
. SEC Classification : ใชภ้ายใน (Internal) FORM 56-1 One Report (Attached to Notification No. Tor Jor. 55/2563) Applicable to the Financial Year Ending 31 December 2021 onwards Annual Registration
historical average price according to the announcement of the Department of Internal Trade, Ministry of Commerce. The Company purchased crude palm oil (CPOA) as at 1 October 2018, the buying average price is
PTA manufacturing plant in Indonesia from PT. Indo-Rama Synthetics Tbk. a connected party. The value of the above acquisition, calculated in accordance with the regulations of the Capital Market
further acquire the remaining 26% equity stake in PT. Indorama Petrochemicals (“PTIP”), a PTA manufacturing plant in Indonesia from PT. Indo-Rama Synthetics Tbk., a connected party. Rationale of the
20230508-ADVANC-MDA-1Q23-EN Classification: Internal 1Q23 MD&A Advanced Info Service Plc. 1 Executive Summary Growing core businesses amid the cautious recovery of the Thai economy 1Q23 illustrated a
20230807-ADVANC-MDA-2Q23-EN Classification: Internal 2Q23 MD&A Advanced Info Service Plc. 1 Executive Summary Core businesses growth from profitability focus amid economic uncertainties In 2Q23 Thai
Control | - |- Compliance / Internal control | - |- Information Technology |- Internal operation of Securities Companies | - |- Outsourcing Services | - |- Appoint service provider OR marketing